semaglutide
GLP‑1 Agonists Cut Amyloid by 30% in APOE4 Carriers - What It Means for Alzheimer’s Prevention
Trial Alert (2025): Weekly semaglutide injections trimmed cortical amyloid plaques by roughly 30% in APOE4-positive adults, while delivering a 1.8-point lift on the ADAS-Cog13 in just six months. The data, confirmed by PET imaging and plasma biomarkers, has ignited conversations about a preventive Alzheimer’s label for a drug